Stay updated on 89Zr-DFO-daratumumab Imaging in Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the 89Zr-DFO-daratumumab Imaging in Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the 89Zr-DFO-daratumumab Imaging in Multiple Myeloma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The displayed site revision changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-10T13:25:41.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error, blocking access to the study record. The 403 content replaces the prior study details and navigation, indicating an access restriction rather than a substantive content update.
    Difference
    18%
    Check dated 2026-09-19T20:39:25.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The study overview no longer shows the condition 'Multiple myeloma'. The 'related topics' section, including the 'MedlinePlus Genetics' entry, is removed.
    Difference
    0.2%
    Check dated 2026-09-12T19:44:33.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The related topics section now includes links for Multiple myeloma and MedlinePlus Genetics, expanding navigational context for readers. This is a minor enhancement to the page's contextual information rather than a change to core study details.
    Difference
    0.2%
    Check dated 2026-09-05T22:21:02.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    The page now shows a revised tag of v3.6.6, replacing the previous v3.6.5, signaling a newer version of the page in the system.
    Difference
    0.1%
    Check dated 2026-08-29T20:08:50.000Z thumbnail image
  8. Check
    61 days ago
    Change Detected
    Summary
    The study page now includes sponsor and investigator information, as well as additional links and expanded study content (protocol and statistical plan, imaging plans, eligibility criteria, and related terminology), enriching the contextual information and navigation of the record. This broader set of metadata reflects a more complete and accessible study documentation.
    Difference
    48%
    Check dated 2026-08-15T14:47:04.000Z thumbnail image

Stay in the know with updates to 89Zr-DFO-daratumumab Imaging in Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the 89Zr-DFO-daratumumab Imaging in Multiple Myeloma Clinical Trial page.